Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells

作者：Guha M; Srinivasan S; Ruthel G; Kashina A K; Carstens R P; Mendoza A; Khanna C; Van Winkle T; Avadhani N G^*

来源：Oncogene, 2014, 33(45): 5238-5250.

DOI：10.1038/onc.2013.467

• mitochondrial DNA
• mitochondrial retrograde signaling
• epithelial-mesenchymal transition
• breast cancer
• ESRP1
• cancer stem cells

Metastatic breast tumors undergo epithelial-to-mesenchymal transition (EMT), which renders them resistant to therapies targeted to the primary cancers. The mechanistic link between mtDNA (mitochondrial DNA) reduction, often seen in breast cancer patients, and EMT is unknown. We demonstrate that reducing mtDNA content in human mammary epithelial cells (hMECs) activates Calcineurin (Cn)-dependent mitochondrial retrograde signaling pathway, which induces EMT-like reprogramming to fibroblastic morphology, loss of cell polarity, contact inhibition and acquired migratory and invasive phenotype. Notably, mtDNA reduction generates breast cancer stem cells. In addition to retrograde signaling markers, there is an induction of mesenchymal genes but loss of epithelial markers in these cells. The changes are reversed by either restoring the mtDNA content or knockdown of CnA alpha mRNA, indicating the causal role of retrograde signaling in EMT. Our results point to a new therapeutic strategy for metastatic breast cancers targeted to the mitochondrial retrograde signaling pathway for abrogating EMT and attenuating cancer stem cells, which evade conventional therapies. We report a novel regulatory mechanism by which low mtDNA content generates EMT and cancer stem cells in hMECs.

• 出版日期2014-11-6